Cristin Print

Print was born in Palmerston North. From an early age he was interested in the mechanics of objects, disassembling and reassembling lawnmowers. Thanks to an influential teacher, he turned his attention to biology in high school.{{Cite web |date=2023 |title=The togetherness needs to be international: 2023 Kea World Class New Zealand Award winner Cristin Print |url=https://keanewzealand.com/cristin-print-2023-kea-world-class-award-winner/ |access-date=31 October 2023 |website=Kea New Zealand}}

Print is married with three children and is an enthusiastic mountain biker.

Print graduated in 1989 from Auckland Medical School with a degree in Medicine and Surgery, and worked as a house surgeon in Dunedin.{{Cite web |last=Yeats |first=Jodi |date=10 February 2022 |title=Professor Cristin Print wins prestigious cancer research award |url=https://www.auckland.ac.nz/en/news/2022/02/09/professor-cristin-print-wins-prestigious-cancer-research-award.html |access-date=2023-10-30 |website=The University of Auckland}}

While working he was a Junior Research Fellow for the Otago Area Health Board, and began research that led to him pursuing a PhD in molecular immunology at the University of Auckland from 1991–1994. Part of the research involved discovering a gene which he named CG-1, after himself and his collaborator Geoff Christensen. His 1995 thesis was titled Investigation of the leucocyte activation antigens CG-1, CD100 and HML-1.{{cite thesis |last=Print |first=Cris |year=1995 |type=Doctoral thesis |title=Investigation of the leucocyte activation antigens CG-1, CD100 and HML-1 |publisher=ResearchSpace@Auckland, University of Auckland |hdl=2292/3194}}

Print continued his research with a four-year postdoctoral fellowship at Walter and Eliza Hall Institute at the University of Melbourne studying apoptosis, the molecular control of programmed cell death. He then moved to Cambridge, where he was a Fellow of St Edmund's College for six years, and became interested in bioinfomatics and genomics. While at Cambridge, he founded a bioinformatics biotechnology company based in Asia, which in 2007 was listed on the Tokyo Stock Exchange.

Print returned to the University of Auckland in 2005, and leads a cross-disciplinary research team investigating human disease, cancer in particular, using bioinformatics, genomics, and system biology. One project used genomic data from 100 Auckland cancer patients to better target therapies, taking into account several hundred genes specific to cancer.{{Cite web |last=Yeats |first=Jodi |date=8 September 2023 |title=Scientist Cristin Print honoured in Kea Awards |url=https://www.auckland.ac.nz/en/news/2023/09/08/scientist-honoured-in-kea-awards.html |access-date=2023-10-30 |website=The University of Auckland}}

As of 2023 he is deputy chair (previously Director and acting chair) and a board member of the Crown Research Institute ESR, and a board member of Cancer Research NZ. He is also a principal investigator in the Healthier Lives National Science Challenge. He was joint director of the University of Auckland's Bioinformatics Institute, and co-leads Rakeiora, a New Zealand genomics infrastructure programme working with indigenous health data in partnership with Māori leaders.

Print has been President of the New Zealand Society for Oncology, and Vice President of the Auckland Museum Institute (Auckland branch of the Royal Society Te Apārangi).

In 2022 Print received a Translational Research Award from the New Zealand Society of Oncology, recognising his "outstanding contributions" to translating scientific findings into clinical practice.

In September 2023 he was one of seven recipients of a World Class New Zealand Award at the Kea World Class Awards.{{Cite web |last=Jones |first=Nick |date=September 2023 |title=Celebrating Prof. Cristin Print, our dear colleague and a World Class Award winner! |url=https://www.nesi.org.nz/news/2023/09/celebrating-prof-cristin-print-our-dear-colleague-and-world-class-award-winner |access-date=31 October 2023 |website=New Zealand eScience Infrastructure}}

• {{Cite journal |last=Henare |first=Kimiora L |last2=Parker |first2=Kate E |last3=Wihongi |first3=Helen |last4=Blenkiron |first4=Cherie |last5=Jansen |first5=Rawiri |last6=Reid |first6=Papaarangi |last7=Findlay |first7=Michael P |last8=Lawrence |first8=Benjamin |last9=Hudson |first9=Maui |last10=Print |first10=Cristin G |date=2019 |title=Mapping a route to Indigenous engagement in cancer genomic research |url=https://linkinghub.elsevier.com/retrieve/pii/S1470204519303079 |journal=The Lancet Oncology |language=en |volume=20 |issue=6 |pages=e327–e335 |doi=10.1016/S1470-2045(19)30307-9|url-access=subscription }}
• {{Cite journal |last=Thomas |first=Alexandra |last2=Routh |first2=Eric D. |last3=Pullikuth |first3=Ashok |last4=Jin |first4=Guangxu |last5=Su |first5=Jing |last6=Chou |first6=Jeff W. |last7=Hoadley |first7=Katherine A. |last8=Print |first8=Cristin |last9=Knowlton |first9=Nick |last10=Black |first10=Michael A. |last11=Demaria |first11=Sandra |last12=Wang |first12=Ena |last13=Bedognetti |first13=Davide |last14=Jones |first14=Wendell D. |last15=Mehta |first15=Gaurav A. |date=2018-10-03 |title=Tumor mutational burden is a determinant of immune-mediated survival in breast cancer |url=https://www.tandfonline.com/doi/full/10.1080/2162402X.2018.1490854 |journal=OncoImmunology |language=en |volume=7 |issue=10 |pages=e1490854 |doi=10.1080/2162402X.2018.1490854 |issn=2162-402X|doi-access=free |pmc=6207420 }}
• {{Cite journal |last=Harris |first=Gavin |last2=O'Toole |first2=Sandra |last3=George |first3=Peter |last4=Browett |first4=Peter |last5=Print |first5=Cristin |date=2017 |title=Massive parallel sequencing of solid tumours – challenges and opportunities for pathologists |url=https://onlinelibrary.wiley.com/doi/10.1111/his.13067 |journal=Histopathology |language=en |volume=70 |issue=1 |pages=123–133 |doi=10.1111/his.13067 |issn=0309-0167|url-access=subscription }}
• {{Cite journal |last=Print |first=Cristin |date=2016 |title=The role of emerging bioinformatic methods in improving diagnosis: A primer for beginners |url=https://linkinghub.elsevier.com/retrieve/pii/S0031302515001038 |journal=Pathology |language=en |volume=48 |pages=S31 |doi=10.1016/j.pathol.2015.12.076|url-access=subscription }}
• {{Cite journal |last=Mehta |first=Sunali |last2=Shelling |first2=Andrew |last3=Muthukaruppan |first3=Anita |last4=Lasham |first4=Annette |last5=Blenkiron |first5=Cherie |last6=Laking |first6=George |last7=Print |first7=Cristin |date=2010 |title=Predictive and prognostic molecular markers for cancer medicine |url=http://journals.sagepub.com/doi/10.1177/1758834009360519 |journal=Therapeutic Advances in Medical Oncology |language=en |volume=2 |issue=2 |pages=125–148 |doi=10.1177/1758834009360519 |issn=1758-8359 |pmc=3126011 |pmid=21789130}}

{{reflist}}

{{Authority control}}

{{DEFAULTSORT:Print, Cris}}

Category:Academic staff of the University of Auckland

Category:New Zealand molecular biologists

Category:New Zealand medical researchers

Category:Cancer researchers

Category:Living people

Category:Year of birth missing (living people)

Category:University of Auckland alumni